Sarah Boschee Krush, NP-C - Medicare Nurse Practitioner in Sioux Falls, SD

Sarah Boschee Krush, NP-C is a medicare enrolled "Nurse Practitioner - Family" physician in Sioux Falls, South Dakota. She graduated from medical school in 2018 and has 6 years of diverse experience with area of expertise as Nurse Practitioner. She is a member of the group practice Sanford Medical Center and her current practice location is 6101 S Louise Ave, Sioux Falls, South Dakota. You can reach out to her office (for appointments etc.) via phone at (605) 322-8000.

Sarah Boschee Krush is licensed to practice in South Dakota (license number CP001400) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1013403583.

Contact Information

Sarah Boschee Krush, NP-C
6101 S Louise Ave,
Sioux Falls, SD 57108-5981
(605) 322-8000
(605) 312-8001



Physician's Profile

Full NameSarah Boschee Krush
GenderFemale
SpecialityNurse Practitioner
Experience6 Years
Location6101 S Louise Ave, Sioux Falls, South Dakota
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Sarah Boschee Krush graduated from medical school in 2018
  NPI Data:
  • NPI Number: 1013403583
  • Provider Enumeration Date: 07/07/2018
  • Last Update Date: 04/25/2022
  Medicare PECOS Information:
  • PECOS PAC ID: 0941621619
  • Enrollment ID: I20200604001952

Medical Identifiers

Medical identifiers for Sarah Boschee Krush such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1013403583NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207Q00000XFamily Medicine F06181624 (South Dakota)Secondary
363LF0000XNurse Practitioner - Family CP001400 (South Dakota)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Sanford Usd Medical CenterSioux falls, SDHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Sanford Medical Center8325950215707

News Archive

Debiopharm launches Phase 1 study of anti-infective agent Debio 1450

Debiopharm Group, a Swiss-based global biopharmaceutical company developing prescription drugs that target unmet medical needs as well as companion diagnostics, today announced the launch of a Phase 1 dose-escalation study of Debio 1450 (previously known as AFN-1720), a highly potent anti-infective agent that is selectively active against a large number of Staphylococcus species, including all known resistant strains such as methicillin-resistant S. aureus (MRSA) and vancomycin-intermediate S. aureus (VISA).

Study seeks to understand how the human brain changes in space

In space, there is no "up" or "down." That can mess with the human brain and affect the way people move and think in space. An investigation on the International Space Station seeks to understand how the brain changes in space and ways to deal with those changes.

Mount Sinai experts to share skin cancer prevention tips on May 7

Skin cancer is the most common form of cancer in the United States, with one in five Americans developing it over the course of their lives. It's also one of the most preventable types of cancers. Since May is Skin Cancer Awareness Month and Melanoma Monday is May 7, Mount Sinai experts are sharing tips on prevention and insight on the new FDA labeling requirements on sunscreen.

Liquidia Technologies completes $20M Series C financing round

Liquidia Technologies, a privately held biopharmaceutical company developing particle-based vaccines and therapeutics, today announced it has completed a $20 million round of Series C financing. Canaan Partners led the Series C round, which also included Pappas Ventures and Morningside Venture Investments Limited as new investors. Previous investors, including New Enterprise Associates and Firelake Capital, also participated in the financing round.

Asian donor and black recipient kidney grafts associated with inferior long-term outcomes

Black transplant recipients and patients who received kidneys from Asian donors had a significantly higher risk of kidney graft failure within seven years, according to a new study presented at the European Society for Organ Transplantation Congress 2021.

Read more Medical News

› Verified 1 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Sarah Boschee Krush allows following entities to bill medicare on her behalf.
Entity NameSanford Clinic
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1396764254
PECOS PAC ID: 0244143824
Enrollment ID: O20031110000532

News Archive

Debiopharm launches Phase 1 study of anti-infective agent Debio 1450

Debiopharm Group, a Swiss-based global biopharmaceutical company developing prescription drugs that target unmet medical needs as well as companion diagnostics, today announced the launch of a Phase 1 dose-escalation study of Debio 1450 (previously known as AFN-1720), a highly potent anti-infective agent that is selectively active against a large number of Staphylococcus species, including all known resistant strains such as methicillin-resistant S. aureus (MRSA) and vancomycin-intermediate S. aureus (VISA).

Study seeks to understand how the human brain changes in space

In space, there is no "up" or "down." That can mess with the human brain and affect the way people move and think in space. An investigation on the International Space Station seeks to understand how the brain changes in space and ways to deal with those changes.

Mount Sinai experts to share skin cancer prevention tips on May 7

Skin cancer is the most common form of cancer in the United States, with one in five Americans developing it over the course of their lives. It's also one of the most preventable types of cancers. Since May is Skin Cancer Awareness Month and Melanoma Monday is May 7, Mount Sinai experts are sharing tips on prevention and insight on the new FDA labeling requirements on sunscreen.

Liquidia Technologies completes $20M Series C financing round

Liquidia Technologies, a privately held biopharmaceutical company developing particle-based vaccines and therapeutics, today announced it has completed a $20 million round of Series C financing. Canaan Partners led the Series C round, which also included Pappas Ventures and Morningside Venture Investments Limited as new investors. Previous investors, including New Enterprise Associates and Firelake Capital, also participated in the financing round.

Asian donor and black recipient kidney grafts associated with inferior long-term outcomes

Black transplant recipients and patients who received kidneys from Asian donors had a significantly higher risk of kidney graft failure within seven years, according to a new study presented at the European Society for Organ Transplantation Congress 2021.

Read more Medical News

› Verified 1 days ago

Entity NamePioneer Memorial Hospital & Health Services
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1619926706
PECOS PAC ID: 9234042755
Enrollment ID: O20031111000252

News Archive

Debiopharm launches Phase 1 study of anti-infective agent Debio 1450

Debiopharm Group, a Swiss-based global biopharmaceutical company developing prescription drugs that target unmet medical needs as well as companion diagnostics, today announced the launch of a Phase 1 dose-escalation study of Debio 1450 (previously known as AFN-1720), a highly potent anti-infective agent that is selectively active against a large number of Staphylococcus species, including all known resistant strains such as methicillin-resistant S. aureus (MRSA) and vancomycin-intermediate S. aureus (VISA).

Study seeks to understand how the human brain changes in space

In space, there is no "up" or "down." That can mess with the human brain and affect the way people move and think in space. An investigation on the International Space Station seeks to understand how the brain changes in space and ways to deal with those changes.

Mount Sinai experts to share skin cancer prevention tips on May 7

Skin cancer is the most common form of cancer in the United States, with one in five Americans developing it over the course of their lives. It's also one of the most preventable types of cancers. Since May is Skin Cancer Awareness Month and Melanoma Monday is May 7, Mount Sinai experts are sharing tips on prevention and insight on the new FDA labeling requirements on sunscreen.

Liquidia Technologies completes $20M Series C financing round

Liquidia Technologies, a privately held biopharmaceutical company developing particle-based vaccines and therapeutics, today announced it has completed a $20 million round of Series C financing. Canaan Partners led the Series C round, which also included Pappas Ventures and Morningside Venture Investments Limited as new investors. Previous investors, including New Enterprise Associates and Firelake Capital, also participated in the financing round.

Asian donor and black recipient kidney grafts associated with inferior long-term outcomes

Black transplant recipients and patients who received kidneys from Asian donors had a significantly higher risk of kidney graft failure within seven years, according to a new study presented at the European Society for Organ Transplantation Congress 2021.

Read more Medical News

› Verified 1 days ago

Entity NameSanford Medical Center
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1821017880
PECOS PAC ID: 8325950215
Enrollment ID: O20040115000388

News Archive

Debiopharm launches Phase 1 study of anti-infective agent Debio 1450

Debiopharm Group, a Swiss-based global biopharmaceutical company developing prescription drugs that target unmet medical needs as well as companion diagnostics, today announced the launch of a Phase 1 dose-escalation study of Debio 1450 (previously known as AFN-1720), a highly potent anti-infective agent that is selectively active against a large number of Staphylococcus species, including all known resistant strains such as methicillin-resistant S. aureus (MRSA) and vancomycin-intermediate S. aureus (VISA).

Study seeks to understand how the human brain changes in space

In space, there is no "up" or "down." That can mess with the human brain and affect the way people move and think in space. An investigation on the International Space Station seeks to understand how the brain changes in space and ways to deal with those changes.

Mount Sinai experts to share skin cancer prevention tips on May 7

Skin cancer is the most common form of cancer in the United States, with one in five Americans developing it over the course of their lives. It's also one of the most preventable types of cancers. Since May is Skin Cancer Awareness Month and Melanoma Monday is May 7, Mount Sinai experts are sharing tips on prevention and insight on the new FDA labeling requirements on sunscreen.

Liquidia Technologies completes $20M Series C financing round

Liquidia Technologies, a privately held biopharmaceutical company developing particle-based vaccines and therapeutics, today announced it has completed a $20 million round of Series C financing. Canaan Partners led the Series C round, which also included Pappas Ventures and Morningside Venture Investments Limited as new investors. Previous investors, including New Enterprise Associates and Firelake Capital, also participated in the financing round.

Asian donor and black recipient kidney grafts associated with inferior long-term outcomes

Black transplant recipients and patients who received kidneys from Asian donors had a significantly higher risk of kidney graft failure within seven years, according to a new study presented at the European Society for Organ Transplantation Congress 2021.

Read more Medical News

› Verified 1 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Sarah Boschee Krush is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Sarah Boschee Krush, NP-C
Po Box 5074,
Sioux Falls, SD 57117-5074

Ph: () -
Sarah Boschee Krush, NP-C
6101 S Louise Ave,
Sioux Falls, SD 57108-5981

Ph: (605) 322-8000

News Archive

Debiopharm launches Phase 1 study of anti-infective agent Debio 1450

Debiopharm Group, a Swiss-based global biopharmaceutical company developing prescription drugs that target unmet medical needs as well as companion diagnostics, today announced the launch of a Phase 1 dose-escalation study of Debio 1450 (previously known as AFN-1720), a highly potent anti-infective agent that is selectively active against a large number of Staphylococcus species, including all known resistant strains such as methicillin-resistant S. aureus (MRSA) and vancomycin-intermediate S. aureus (VISA).

Study seeks to understand how the human brain changes in space

In space, there is no "up" or "down." That can mess with the human brain and affect the way people move and think in space. An investigation on the International Space Station seeks to understand how the brain changes in space and ways to deal with those changes.

Mount Sinai experts to share skin cancer prevention tips on May 7

Skin cancer is the most common form of cancer in the United States, with one in five Americans developing it over the course of their lives. It's also one of the most preventable types of cancers. Since May is Skin Cancer Awareness Month and Melanoma Monday is May 7, Mount Sinai experts are sharing tips on prevention and insight on the new FDA labeling requirements on sunscreen.

Liquidia Technologies completes $20M Series C financing round

Liquidia Technologies, a privately held biopharmaceutical company developing particle-based vaccines and therapeutics, today announced it has completed a $20 million round of Series C financing. Canaan Partners led the Series C round, which also included Pappas Ventures and Morningside Venture Investments Limited as new investors. Previous investors, including New Enterprise Associates and Firelake Capital, also participated in the financing round.

Asian donor and black recipient kidney grafts associated with inferior long-term outcomes

Black transplant recipients and patients who received kidneys from Asian donors had a significantly higher risk of kidney graft failure within seven years, according to a new study presented at the European Society for Organ Transplantation Congress 2021.

Read more News

› Verified 1 days ago



Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.